The differential formation of excitatory (glutamate-mediated) and inhibitory (GABA-mediated) synapses is a critical step for the proper functioning of the brain. An imbalance in these synapses may lead to various neurological disorders such as autism, schizophrenia, Tourette's syndrome and epilepsy [1] [2] [3] [4] . Synapses are formed through communication between the appropriate synaptic partners [5] [6] [7] [8] . However, the molecular mechanisms that mediate the formation of specific synaptic types are not known. Here we show that two members of the fibroblast growth factor (FGF) family, FGF22 and FGF7, promote the organization of excitatory and inhibitory presynaptic terminals, respectively, as target-derived presynaptic organizers. FGF22 and FGF7 are expressed by CA3 pyramidal neurons in the hippocampus. The differentiation of excitatory or inhibitory nerve terminals on dendrites of CA3 pyramidal neurons is specifically impaired in mutants lacking FGF22 or FGF7. These presynaptic defects are rescued by postsynaptic expression of the appropriate FGF. FGF22-deficient mice are resistant to epileptic seizures, and FGF7-deficient mice are prone to them, as expected from the alterations in excitatory/inhibitory balance. Differential effects of FGF22 and FGF7 involve both their distinct synaptic localizations and their use of different signalling pathways. These results demonstrate that specific FGFs act as target-derived presynaptic organizers and help to organize specific presynaptic terminals in the mammalian brain.
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Target (postsynaptic cell)-derived 'presynaptic organizers' promote the local differentiation of presynaptic axons into functional nerve terminals at sites of synaptic contact [5] [6] [7] [8] . This presynaptic differentiation includes the clustering of synaptic vesicles, the formation of active zones, cytoskeletal restructuring and the assembly of vesicle recycling machinery [5] [6] [7] [8] . We have identified FGF22 and its close relatives, FGF7 and FGF10, as molecules that can promote the differentiation of presynaptic nerve terminals 9 . Using blocking reagents and mice deficient in their main receptor FGFR2, we showed that these FGFs are involved in presynaptic differentiation in the cerebellum 9 and at the neuromuscular junction 10 . Here we investigate the specific synaptogenic function of FGF22 and FGF7, using FGF22-knockout (KO) ( Supplementary Fig. 1 ) and FGF7KO mice 11 . In situ hybridization revealed that fgf22 and fgf7 messenger RNAs were strongly expressed in the mouse hippocampus at 8 days after birth (P8; Fig. 1a) , which is about the time that synapses start to form 12, 13 . They were highly expressed by CA3 pyramidal neurons, but very little expression was found in CA1 pyramidal neurons. mRNAs for FGFR2 (Fig. 1b) and FGFR1 (ref. 14) , which are possible receptors for FGF22 and FGF7 (ref. 15) , were expressed by various neurons throughout the hippocampus. Both FGF22 and FGF7 proteins were localized in the synapse-rich areas, stratum radiatum and stratum lucidum, in CA3 (Fig. 1c) , supporting the idea that these FGFs are involved in synapse formation in CA3.
To address the question of whether synapses in CA3 require FGF22 and FGF7 for presynaptic differentiation, we measured synaptic vesicle clustering in FGF22KO and FGF7KO mice. Their hippocampus looked anatomically normal and the fate of cells seemed to be unchanged ( Supplementary Fig. 2 ). However, clustering of the synaptic vesicle protein SV2 was significantly decreased in CA3 in both FGF22KO and FGF7KO mice compared with wild-type (WT) mice ( Fig. 2a and Supplementary Fig. 3b ) at P14, when synaptogenesis is at its peak 12, 13 . Synaptic vesicle clustering in CA1 was normal. Thus, FGF22 and FGF7 are involved in presynaptic differentiation in CA3 but not in CA1; this is consistent with the mRNA expression of these FGFs (Fig. 1a) . The clustering of bassoon, an active-zone marker, was not significantly different between the WT and FGFKO hippocampus ( Fig. 2b and Supplementary Fig. 3c ), suggesting that active-zone formation and synaptic vesicle clustering are relatively independent. during synapse formation at P8. a, fgf22 and fgf7 mRNAs are highly expressed in CA3 pyramidal neurons (arrowheads) but not in CA1 pyramidal neurons. The bottom panels are negative controls using FGFKO sections. b, fgfr2 mRNA is widely expressed throughout the hippocampus. c, FGF22 and FGF7 proteins are localized in CA3 synapse-rich areas.
The defect of synaptic vesicle clustering in either FGFKO CA3 was incomplete (Fig. 2a) , suggesting that each FGF acts on only a subset of synapses. We examined whether FGF22 and FGF7 are differentially involved in glutamatergic and GABAergic presynaptic differentiation. At P14, vesicle clustering at glutamatergic synapses, monitored by staining of vesicular glutamate transporter 1 (VGLUT1), was significantly decreased in CA3 of FGF22KO mice but not in FGF7KO mice, relative to WT mice (Fig. 2c) . In contrast, GABAergic synaptic vesicle clustering, monitored by vesicular GABA transporter (VGAT) staining, was significantly decreased in FGF7KO mice but not in FGF22KO mice (Fig. 2d) . The clustering of postsynaptic density protein 95 (PSD95) and gephyrin, postsynaptic scaffolding proteins at glutamatergic and GABAergic synapses, respectively, was not significantly affected in either KO mouse ( Fig. 2e and Supplementary  Fig. 3d, e) . The morphology of CA3 pyramidal neurons and interneurons and the projections of dentate gyrus axons in FGFKO mice were similar to those in WT mice ( Supplementary Fig. 4 ). Thus, FGF22 and FGF7 seem to be specifically involved in glutamatergic and GABAergic presynaptic differentiation, respectively. The presynaptic defects in FGFKO mice could be detected from early stages of synapse formation 12, 13 (P8) to adulthood (Supplementary Figs 5 and 6 ), suggesting that FGF inactivation prevents presynaptic differentiation rather than just delaying it.
We then examined the ultrastructure of synapses formed in CA3 of FGFKO mice. We identified excitatory and inhibitory synapses on the basis of their morphology: asymmetric as excitatory and symmetric as inhibitory. In FGF22KO, FGF7KO and WT CA3, we found a similar number of asymmetric and symmetric synapses (Fig. 2f, i) . At asymmetric synapses (Fig. 2g) , synaptic vesicles in FGF22KO mice, but not those in FGF7KO mice, were more diffusely distributed and smaller than those in WT mice (Fig. 2h) . In addition, the number of docked vesicles was significantly decreased in FGF22KO mice. In contrast, at symmetric synapses (Fig. 2j) , the number of total synaptic vesicles in each presynaptic terminal and their size were significantly decreased in FGF7KO mice but not in FGF22KO mice (Fig. 2k) . Thus, FGF22 and FGF7 are specifically involved in the presynaptic differentiation of excitatory and inhibitory synapses, respectively, in CA3. As western blots showed, the total level of VGLUT1 and VGAT proteins in CA3 was not changed in FGFKO mice (610%; Fig. 2l ), suggesting that the presynaptic defects in FGFKO mice are due to an impairment of synaptic vesicle recruitment and not its formation.
Next we investigated whether the differentiation of glutamatergic and GABAergic terminals on a neuron is controlled by FGF expression in that neuron. Overexpression of FGF22 and FGF7 in cultured hippocampal neurons led to an increase in the clustering of VGLUT1 and VGAT puncta, respectively, on the FGF-expressing neuron (Fig. 3a) . This suggests that FGF22 and FGF7 specifically promote the differentiation of glutamatergic and GABAergic presynaptic terminals, respectively, as target-derived molecules.
If FGFs are target-derived presynaptic organizers, the differentiation of presynaptic terminals on the dendrites of CA3 pyramidal neurons, which express fgf22 and fgf7 mRNAs (Fig. 1a) , should be severely and specifically impaired in FGFKO mice. To test this idea, we identified CA3 pyramidal neurons in hippocampal cultures with the antibody Py, which is specific for the dendrites and cell body of CA3 pyramidal neurons 16 . At 14 days in vitro (14 DIV), relative to WT cultures, the clustering of glutamatergic (VGLUT1) and GABAergic (VGAT) vesicles associated with dendrites of CA3 pyramidal neurons was markedly decreased in FGF22KO and FGF7KO cultures, respectively ( Fig. 3b and Supplementary Fig. 7 ). In contrast, we did not detect significant defects in presynaptic terminals associated with other neuronal populations (Fig. 3c) . The presynaptic defects on CA3 pyramidal cell dendrites appeared early in culture (10 DIV), and even after 21 DIV very little apparent presynaptic differentiation was observed (Supplementary Fig. 8 ). These presynaptic defects in FGF22KO and FGF7KO cultures were rescued by FGF22 or FGF7 expression in postsynaptic CA3 pyramidal cells (Fig. 3d) . Taken together, these results support the idea that FGF22 and FGF7 are critical as target-derived molecules for the clustering of specific types of synaptic vesicle to presynaptic terminals formed on CA3 pyramidal neurons.
We also performed a series of control experiments, which suggest that FGF deficiency specifically affects synaptic vesicle clustering. First, the number and morphology of Py-positive neurons, interneurons and dentate gyrus neurons were similar in FGFKO and WT cultures ( Supplementary Fig. 9 ). Second, the clustering of bassoon, postsynaptic receptors and scaffolding proteins was not impaired in FGFKO cultures (Supplementary Figs 7 and 10) . Third, VGLUT1 and VGAT proteins seemed to be properly localized and functional at synaptic vesicles, because they were not stuck in cell bodies ( Supplementary Fig. 11 ) and the quantal size, as measured by electrophysiological recordings, was normal in FGFKO neurons (Fig. 4a-d) .
To understand the mechanisms by which FGF22 and FGF7 mediate differential presynaptic effects, we examined their synaptic localization. When enhanced green fluorescent protein (EGFP)-tagged FGF22 and DsRed-tagged FGF7 were transfected into hippocampal cultures, both FGFs localized to MAP2-positive dendrites and not to neurofilament-positive axons (Supplementary Fig. 12 ). In dendrites, more than 85% of FGF22-EGFP was co-localized with PSD95 (Fig. 3e) but not with gephyrin (less than 6%). In contrast, more than 85% of FGF7-DsRed was co-localized with gephyrin ( Fig. 3f) and not with PSD95 (less than 8%). Endogenous FGF22 and FGF7 puncta were also associated with PSD95 and VGAT puncta, respectively (more than 85% and more than 75%; Fig. 3g ). FGF22-EGFP and FGF7-DsRed showed non-overlapping expression (Fig. 3h) , which confirms that FGF22 and FGF7 are targeted to different dendritic subdomains. Thus, in hippocampal neurons, FGF22 and FGF7 are specifically localized at glutamatergic and GABAergic synapses, respectively, which probably accounts for their differential effects on excitatory and inhibitory synapse development.
We then tested the additional possibility that FGF22 and FGF7 activate different signalling pathways for their differential effects. When we applied the maximum effective concentration of recombinant FGFs 9, 15 to WT hippocampal cultures, only FGF22 significantly increased the number of VGLUT1-positive puncta (Fig. 3i) . In contrast, both FGF22 and FGF7 were able to increase the number and size of VGAT-positive puncta (Fig. 3j) ; however, the effect of FGF7 was more marked than that of FGF22. Thus, even when exogenously applied, FGF22 and FGF7 showed limited specificity on presynaptic differentiation, suggesting that they activate different sets of signalling pathways. Different signalling pathways might be mediated by distinct FGF receptors. An in vitro assay showed that FGF7 signals preferentially through FGFR2b, whereas FGF22 signals through both FGFR2b and FGFR1b 15 . The analysis of conditional FGFR2KO mice, in which fgfr2 is inactivated postnatally with the ) and size of VGLUT1 (i) or VGAT (j) puncta after bath application of FGF to WT cultures. k, Staining intensity of VGLUT1 and VGAT in control and FGFR2KO CA3 sections (P8). l, Normalized staining intensity of FGFR2KO sections. Error bars indicate s.e.m. Data are from 50-290 neurites or 8-66 fields from at least three experiments. Significant differences from control: asterisk, P , 0.05; two asterisks, P , 0.01; three asterisks, P , 0.001, t-test (d, k, l) or analysis of variance followed by Tukey test; hash sign, P 5 0.073 (i). Scale bars, 10 mm.
Cre-ER system 9, 10 , is consistent with this receptor specificity. We found that the clustering of both glutamatergic and GABAergic vesicles was decreased in FGFR2KO CA3 (Fig. 3k) , but the decrease was more pronounced at GABAergic than at glutamatergic synapses (Fig. 3l) . These results suggest that the differential effects of FGF22 and FGF7 are achieved by their distinct synaptic localizations and use of different receptors.
To investigate the functional consequences of the impaired presynaptic differentiation in FGFKO neurons, we recorded synaptic currents. We found that the frequency, but not the amplitude, of miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs) was specifically decreased in FGF22KO and FGF7KO hippocampal cultures, respectively (Fig. 4a-d and Supplementary Fig.  13a, b) . Paired-pulse facilitation and synaptic depression in response to a stimulus train were both increased in FGF22KO neurons relative to WT neurons ( Supplementary Fig. 13c-f) , suggesting that release probability and the readily releasable vesicle pool are both diminished in the absence of FGF22. FGF22KO and FGF7KO neurons therefore seem to have specific defects in excitatory and inhibitory presynaptic function, respectively. These results also suggest that postsynaptic differentiation is relatively independent of presynaptic differentiation, which is similar to findings from FGF14 (FHF4) KO mice 17 . A synaptic imbalance in the hippocampus may contribute to various neurological disorders, including epilepsy 4 . We therefore subjected FGFKO and control animals to the kindling protocol, an animal model of epilepsy 18, 19 . We injected adult animals with pentylenetetrazol, a GABA receptor antagonist, every 48 h to induce epileptic seizures 18, 19 . Most FGF7KO mice developed major seizures (kindled) sooner than control mice did (Fig. 4e) . In contrast, none of the FGF22KO mice were kindled within the period examined (30 injections). When about half of control mice were kindled (about 21 injections; 52.5 6 3.8% (mean 6 s.e.m.)), no FGF22KO mice were kindled, whereas most FGF7KO mice were kindled (83.3 6 4.4%; Fig. 4f ). Thus, FGF22KO mice are resistant to epileptic seizures and FGF7KO mice are prone to them, indicating that synaptogenic effects by FGFs have lifelong consequences.
Using in vivo and in vitro approaches, we have identified FGF22 and FGF7 as target-derived presynaptic organizers for excitatory and inhibitory synapses in the hippocampal CA3 region (Fig. 4g) . How FGFs work together with other synaptogenic molecules such as neuroligins, Ephs/ephrins, brain-derived neurotrophic factor, WNTs, SynCAMs, netrin-G ligands, thrombospondins [6] [7] [8] , signal regulatory proteins 20 and LRRTMs (leucine-rich repeat transmembrane proteins) 21 , activitydependent regulators such as Npas4 (ref. 22) , and glial cells 6, 7 to coordinate appropriate synapses will be an important next question to be answered.
Selective synaptic targeting of FGFs might also contribute to the spatial restriction of FGF effects. Indeed, we did not find significant defects in stratum lacunosum moleculare in CA3 of FGFKO mice (not shown). Such spatial specificity was also observed in neuroligin-2 KO mice 23 . It will be interesting to address the mechanisms by which FGF22 and FGF7 localize differentially in hippocampal neurons.
The impairment of presynaptic differentiation in FGFKO mice has a significant consequence for brain function: altered seizure susceptibility. Future inquiries should address whether these FGFs are expressed abnormally in epileptic patients, and whether the application or blockade of FGFs/FGFRs alleviates seizures. These studies will help in the design of appropriate strategies for the treatment and prevention of epilepsy and other neurological disorders with abnormal synapse formation.
METHODS SUMMARY
Knockout mice. All studies reported in this manuscript were performed on littermate offsprings derived from heterozygote matings. FGF7KO mice were from the Jackson Laboratory 11 . FGF22KO mice were generated by replacing exon 1 and a part of exon 2 of the fgf22 gene with the neomycin-resistant gene ( Supplementary Fig. 1 ) by means of homologous recombination (performed by Deltagen). Actin-Cre-ER transgenic and conditional FGFR2KO mice were described previously 9, 10 . Tamoxifen (100 mg) was injected at P0. All animal care and use was in accordance with the institutional guidelines and approved by the University Committee on Use and Care of Animals. Histology. Hippocampal sections and neurons were immunostained and imaged with an epifluorescence microscope (Olympus) or a confocal microscope (FV1000, Olympus). Synaptic protein clustering was measured with MetaMorph software as described previously 9 . For quantification in brain sections, areas were chosen randomly and the average staining intensity (on a scale of 0 to 4,095) was quantified for each area. The staining intensity of the fimbria hippocampus in the same section was subtracted. For quantification in cultures, neurites or fields were randomly selected and thresholded (see Supplementary Fig. 7) , and the number and average size of puncta were quantified. Co-localization indices were determined with MetaMorph software. Images of single fluorescence channels were thresholded and binarized. An object was considered to co-localize if more than 25% of its area was covered by the signal in the second channel. . Error bars indicate s.e.m. Significant differences from control: asterisk, P , 0.05; three asterisks, P , 0.001; analysis of variance followed by Tukey test. g, Summary model. FGF22 and FGF7 from CA3 pyramidal neurons promote the differentiation of excitatory and inhibitory presynaptic terminals, respectively. FGF22 and FGF7 are localized at corresponding synapses and activate differential signalling pathways for specific presynaptic differentiation.
postsynaptic currents were obtained at a holding potential of 270 mV and analysed with Minianalysis (Synaptosoft).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
